IP Verse

Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)

Patent No. EP3666797 (titled "Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)") was filed by Amgen on Aug 22, 2008. The application was issued on May 17, 2023.

Patent Summary

Monoclonal antibodies that bind to the catalytic domain of PCSK9, a cholesterol-lowering protein, and prevent or reduce the binding of PCSK9 to LDLR. These antibodies can be used to treat or prevent hypercholesterolemia and atherosclerotic diseases by inhibiting PCSK9's function. The antibodies bind to specific regions of PCSK9's heavy and light chain variable domains.

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_CFI_0002221/2025Dec 23, 2025AmgenGeneric
UPC_CFI_0002220/2025Dec 23, 2025AmgenGeneric
APP_3214/2025Jan 21, 2025Name NOT Displayed FOR Gdpr Reasons Represented BY Sture Rygaard, Redacted Natural Person NameGeneric
UPC_COA_529/2024Sep 13, 2024AmgenAppeal
UPC_COA_528/2024Sep 13, 2024AmgenAppeal
APP_47172/2024Aug 14, 2024DehnsGeneric
APP_47163/2024Aug 14, 2024DehnsGeneric
APP_47154/2024Aug 14, 2024DehnsGeneric
CC_586764/2023Nov 10, 2023Regeneron PharmaceuticalsCounter Claim For Revocation
APP_546231/2023Jul 11, 2023Name NOT Displayed FOR Gdpr Reasons Represented BY Oswin Ridderbusch, Redacted Natural Person NameGeneric

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
REGENERON PHARMACEUTICALSFeb 19, 2024ZWICKER
SANOFI AVENTIS DEUTSCHLANDNov 10, 2023CARPMAELS & RANSFORD
SANOFI AVENTIS DEUTSCHLAND SANOFI AVENTIS GROUPE SANOFI WINTHROP INDUSTRIENov 10, 2023CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3666797

AMGEN
Application Number
EP19207796A
Filing Date
Aug 22, 2008
Status
Granted And Under Opposition
Apr 14, 2023
Publication Date
May 17, 2023
External Links
Slate, Register , Google Patents